India Cabinet Defers Decision On Whether To Restrict Pharma FDI
This article was originally published in PharmAsia News
Executive Summary
India's Cabinet pushed back at least a few days its decision on whether to lower the percentage of foreign direct investment from today's 100% to 49% in critical areas of the drug industry.